Skip to main content

RM Catalyst consortium reports reveal Australia’s potential

By November 11, 2021November 15th, 2021No Comments

The RM Catalyst consortium recently published two reports revealing Australia’s potential to become a global leader in the regenerative medicine sector.

With a reputation for delivering high-quality, complex, and safe medical products, as well as a highly-skilled workforce, the reports highlights how Australia can become a clinical trial and manufacturing hub to deliver potentially life-changing treatments to patients, both locally and globally.

Read Reports